small-volume and micrometastatic diseaseLutetium-177-DOTATATE177Lu-DOTATATE177Lu-PSMA-617177Lu-prostate-specific membrane antigen-617
…ith higher biological effectiveness and potential advantages in small-volume and micrometastatic disease. Innovations in ligand and vector engineering (including half-l…